Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Oncologist|April 2, 2021
Neoadjuvant Everolimus for Adult Giant Mesenteric Cystic Lymphangioma with mTOR Pathway ActivationSophie El Zein, Nadège Gruel, Sylvie Bonvalot, et al.
The American Journal of Pathology|September 21, 2013
PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumorsSardar F Mahmood, Nadège Gruel, Rémy Nicolle, et al.
Oncogene|June 15, 2004
Gene expression profiling of 1p35-36 genes in neuroblastomaIsabelle Janoueix-Lerosey, Eugene Novikov, Marta Monteiro, et al.
Methods (San Diego, Calif.)|August 18, 2004
Generation of functional scFv intrabodies for triggering anti-tumor immunityEmmanuelle Bonnin, Nadège Gruel, Sandrine Moutel, et al.
Cancer Cell|April 10, 2007
JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomasOdette Mariani, Caroline Brennetot, Jean-Michel Coindre, et al.
Cancer Research|September 2, 2008
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancerIsabelle Bernard-Pierrot, Nadège Gruel, Nicolas Stransky, et al.
Frontiers in Immunology|October 31, 2022
CXCR6 expressing T cells: Functions and role in the control of tumorsNesrine Mabrouk, Thi Tran, Ikuan Sam, et al.
Breast (Edinburgh, Scotland)|April 26, 2012
High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patientsAnne Vincent-Salomon, David Hajage, Alexandre Rouquette, et al.
Oncotarget|October 2, 2015
First description of a sporadic breast cancer in a woman with BRCA1 germline mutationElsa Curtit, Vanessa Benhamo, Nadège Gruel, et al.
Breast Cancer Research : BCR|February 19, 2016
LIN7A is a major determinant of cell-polarity defects in breast carcinomasNadège Gruel, Laetitia Fuhrmann, Catalina Lodillinsky, et al.
Pageof 4